Basdai
BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) is a diagnostic tool used to determine the disease activity in patients with ankylosing spondylitis (AS). It is a self-administered questionnaire that helps in assessing the effectiveness of treatments and the progression of the disease.
Overview[edit | edit source]
The BASDAI was developed by rheumatologists at the Royal National Hospital for Rheumatic Diseases in Bath, United Kingdom. It is widely used in both clinical practice and research settings to evaluate the severity of symptoms in patients with ankylosing spondylitis.
Components[edit | edit source]
The BASDAI consists of six questions that measure the following symptoms over the past week:
- Fatigue
- Spinal pain
- Joint pain/swelling
- Areas of localized tenderness (also known as enthesitis)
- Morning stiffness duration
- Morning stiffness severity
Each question is scored on a scale from 0 (no problem) to 10 (worst problem). The final BASDAI score is calculated by averaging the scores of the first five questions and adding the score of the sixth question, then dividing by five.
Scoring and Interpretation[edit | edit source]
A BASDAI score of 4 or higher is generally considered indicative of active disease, which may necessitate a change in treatment. The score helps healthcare providers to make informed decisions regarding the management of ankylosing spondylitis, including the use of nonsteroidal anti-inflammatory drugs (NSAIDs), biologic therapy, and physical therapy.
Clinical Use[edit | edit source]
The BASDAI is used in conjunction with other diagnostic tools such as the Bath Ankylosing Spondylitis Functional Index (BASFI) and imaging studies like magnetic resonance imaging (MRI) to provide a comprehensive assessment of disease activity and functional impairment in patients with ankylosing spondylitis.
Related Pages[edit | edit source]
- Ankylosing spondylitis
- Bath Ankylosing Spondylitis Functional Index
- Nonsteroidal anti-inflammatory drugs
- Biologic therapy
- Physical therapy
- Magnetic resonance imaging
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
